Alterations in Claudin-2 (CLDN2), a component of cellular tight junction, are involved in the progression of a variety of cancer types (Buchert et al., 2010; Tabariès et al., 2011; Tabariès et al., 2012). The gene discussed is CLDN2; the disease is cancer.